- Home
- LRHC vs SNOA Comparison
LRHC vs SNOA Comparison
Compare LRHC & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRHC
- SNOA
- Stock Information
- Founded
- LRHC 2004
- SNOA 1999
- Country
- LRHC United States
- SNOA United States
- Employees
- LRHC N/A
- SNOA N/A
- Industry
- LRHC
- SNOA Biotechnology: Pharmaceutical Preparations
- Sector
- LRHC
- SNOA Health Care
- Exchange
- LRHC Nasdaq
- SNOA Nasdaq
- Market Cap
- LRHC 5.6M
- SNOA 6.4M
- IPO Year
- LRHC 2023
- SNOA 2007
- Fundamental
- Price
- LRHC $0.14
- SNOA $2.90
- Analyst Decision
- LRHC
- SNOA
- Analyst Count
- LRHC 0
- SNOA 0
- Target Price
- LRHC N/A
- SNOA N/A
- AVG Volume (30 Days)
- LRHC 4.1M
- SNOA 33.3K
- Earning Date
- LRHC 08-14-2025
- SNOA 06-17-2025
- Dividend Yield
- LRHC N/A
- SNOA N/A
- EPS Growth
- LRHC N/A
- SNOA N/A
- EPS
- LRHC N/A
- SNOA N/A
- Revenue
- LRHC $73,874,281.00
- SNOA $14,288,000.00
- Revenue This Year
- LRHC N/A
- SNOA $38.54
- Revenue Next Year
- LRHC N/A
- SNOA N/A
- P/E Ratio
- LRHC N/A
- SNOA N/A
- Revenue Growth
- LRHC 90.36
- SNOA 12.20
- 52 Week Low
- LRHC $0.09
- SNOA $1.75
- 52 Week High
- LRHC $2.40
- SNOA $9.37
- Technical
- Relative Strength Index (RSI)
- LRHC 50.50
- SNOA 38.85
- Support Level
- LRHC $0.12
- SNOA $2.81
- Resistance Level
- LRHC $0.15
- SNOA $3.45
- Average True Range (ATR)
- LRHC 0.01
- SNOA 0.13
- MACD
- LRHC 0.00
- SNOA -0.05
- Stochastic Oscillator
- LRHC 57.43
- SNOA 10.77
About LRHC La Rosa Holdings Corp.
La Rosa Holdings Corp operates in the U.S. residential real estate market. It is a holding company for agent-centric, technology-integrated, cloud-based, multi-service real estate companies. The company's business is organized based on the services it provides internally to the agents and to the public, which are residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The company has six reportable segments, namely: Real Estate Brokerage Services (Residential), Franchising Services, Coaching Services, Property Management, Real Estate Brokerage Services (Commercial), and Title Settlement and Insurance. It derives maximum revenue from the Real Estate Brokerage Services (Residential) segment.
About SNOA Sonoma Pharmaceuticals Inc.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.